SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AMEV-Applied Molecular Evolution
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
164 16 0 AMEV
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
114>>SAN DIEGO, Oct. 2 /PRNewswire-FirstCall/ -- Applied Molecular Evolution,tuck-10/2/2003
113I wrote: <i> 2. The hope for Numax is that with increased potency, at the keokalani'nui-10/1/2003
112MedImmune Files Numax(TM) Investigational New Drug Application Wednesday Octoberkeokalani'nui-10/1/2003
111MEDI licenses the DYAX libraries: Message 19355117nigel bates-9/30/2003
110They've got to be preparing the financing. Should be an easy, bought deal. keokalani'nui-9/23/2003
109Indeed, AMEV part of the froth with good news (though not earth-shaking news) putuck-9/22/2003
108And the best news is it will be a while before there is any possibility of bad nkeokalani'nui-9/18/2003
107Nice breakout again. Very strong last two months, though the volume is not wherVIXandMore-9/18/2003
106MedImmune Initiates Two Phase 2 Clinical Trials for Vitaxin(R) Tuesday Septemberkeokalani'nui-9/9/2003
105>>3. 'Just a few amino acid changes'--made it sound like no big dekeokalani'nui-8/6/2003
104Applied Molecular Evolution, Inc. - Selected Financial Data VIXandMore-8/5/2003
103Applied Molecular Evolution, Inc. Reports Financial Results for Second Quarter 2VIXandMore-8/5/2003
102More amev follow-up re: Medi conf. There was less insight offered than I expeckeokalani'nui-6/27/2003
101Snips from today's update from MEDI: >>Vitaxin Edward M. Connor, M.Dtuck-6/27/2003
100Dow Jones Business News Genmab Says Cancer Antibody Shows "Promising Resultkeokalani'nui-6/26/2003
99MedImmune Announces 2003 Business Review Meeting With Investors and Analysts Gkeokalani'nui-6/24/2003
98That makes 3 separate deals with LLY since 12/00 covering 5 compounds: 3 antibodrkrw-6/24/2003
97Applied Molecular Evolution Enters Into Third Collaboration With Lilly for Optimnigel bates-6/24/2003
96Genentech And IDEC Announce Humanized Anti-CD20 Antibody Development Collaboratikeokalani'nui-6/21/2003
95>>I noticed it in the medx annual report. Where have you seen the "moIcebrg-6/13/2003
94I noticed it in the medx annual report. Where have you seen the "more potenrkrw-6/13/2003
93Had not noticed before that medx has supplied a 'fully human remicade' tkeokalani'nui-6/13/2003
92Nice volume folks. EOM.keokalani'nui-5/27/2003
91Applied Molecular Evolution, Inc. Reports Financial Results for First Quarter 20mopgcw-5/23/2003
90Thank you for that rkrw! EOM.keokalani'nui-4/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News